NCT04957901View on ClinicalTrials.gov

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

Lymphoma

Interventions

DRUG

Pediatric lymphoma protocol

The tumor tissue (FFPE) and plasma samples (bone marrow or cerebrospinal fluid samples if necessary) from the newly diagnosed patients were collected and sequenced by 475 genes panel before, during and post treatment.

Trial Locations (1)

Unknown

RECRUITING

Yizhuo Zhang, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER